Press Releases BB Biotech AG Swiss Exchange

Equities

Market Closed - Swiss Exchange Other stock markets 12:01:39 13/04/2022 pm IST			5-day change	1st Jan Change
64.4 ^CHF	+31.97%		-.--%	-.--%

27/04	Tranche Update on BB Biotech AG?s Equity Buyback Plan announced on April 12, 2022.	CI
26/04	Switzerland's BB Biotech Swings to Q1 Profit; Operating Income Jumps	MT

DD: BB BIOTECH AG: Dr. Thomas von Planta, buy	02/05	EQ
BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates	26/04	EQ
BB Biotech AG publishes its interim report	26/04	EQ
DD: BB BIOTECH AG: Dr. Thomas von Planta, buy	26/03	EQ
DD: BB BIOTECH AG: Dr. Thomas von Planta, buy	26/03	EQ
Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share	21/03	EQ
DD: BB BIOTECH AG: Prof. Dr. Mads Krogsgaard Thomsen, buy	21/02	EQ
BB Biotech AG publishes its 2023 annual report	16/02	EQ
Investor interest returns – dividend yield remains high for 2024	14/02	EQ
BB Biotech AG: End of year biotech equity market rally – M&A and end of rate hike cycle	19/01	EQ
BB Biotech AG publishes financial results for 2023 and changes to the Board of Directors	19/01	EQ
BB Biotech AG publishes its interim report	20/23/20	EQ
BB BIOTECH AG: Biotech equity markets in flux: the impact of rising bond yields and shifting healthcare policies	20/23/20	EQ
BB Biotech : Q3 2023 Interim Report	20/23/20	PU
BB Biotech : Delisting from Borsa Italiana	21/23/21	PU
BB Biotech AG publishes its interim report	21/23/21	EQ
BB BIOTECH AG: Sector rotation and fund outflows weigh on biotech stocks, but positive developments allow fund raising to strengthen industry	21/23/21	EQ
BB BIOTECH AG: Creating blockbuster drugs using algorithms	03/23/03	EQ
BB BIOTECH AG: Lackluster first quarter for biotech stocks	21/23/21	EQ
BB Biotech AG publishes its interim report	21/23/21	EQ

No results for this search